New designer drug found in Toronto fentanyl supply

Résumé détaillé
A new opioid part of an emerging class of designer drugs has been found in fentanyl samples in Toronto, according to a drug monitoring program.
A new opioid part of an emerging class of designer drugs has been found in fentanyl samples in Toronto, according to a drug monitoring program.
It’s the sixth new substance to be found in the city’s fentanyl supply so far this year, as reported by Toronto’s Drug Checking Service, raising concerns about the ongoing contamination and ever-changing nature of the street supply driving Canada’s opioid overdose crisis.
Karen McDonald, executive director of the drug checking service that operates out of St. Michael’s Hospital, said little is known about the new drug that was first found in four fentanyl samples in October. It is so new, it doesn’t even have a generic name yet.
N’-Phenethyl-5-chloro nor-orphine or N’-Phenethyl-6-chloro nor-orphine — the two drugs are so chemically similar the drug checking service said it can’t currently differentiate between them — has also been detected in Vancouver.
The drug is part of the orphine class of opioids, a potent group of designer drugs that have increasingly been on the radar of global monitors.
Late last year, Toronto’s Drug Checking Service started finding cychlorphine, an orphine-class opioid believed to be about 10 times stronger than fentanyl, in the city’s illicit drug supply.
But with next to no available research, the strength and effects of the novel orphine found in Toronto and Vancouver in October is unknown, McDonald said.
“This is a really good example of what we’re dealing with, with the unregulated fentanyl supply. It is just evolving, and the substances that are presenting are incredibly novel,” she said.
Cristiana Stefan, a lab director and clinical biochemist at the Centre for Addiction and Mental Health, has concerns about how the orphine may interact with other drugs.
Début de l'article, extrait de Global News. Pour lire la suite, ouvrez l'article chez le média.
MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (globalnews.ca)


